Cargando…
Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
Autores principales: | Lim, Key-Hwan, Yang, Sumin, Kim, Sung-Hyun, Joo, Jae-Yeol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834154/ https://www.ncbi.nlm.nih.gov/pubmed/32619698 http://dx.doi.org/10.1016/j.jinf.2020.06.072 |
Ejemplares similares
-
Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer’s Disease Patients Group Brain Using Genome-Wide Association Study Approach
por: Lim, Key-Hwan, et al.
Publicado: (2021) -
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020) -
SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022) -
Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer’s Disease
por: Lim, Key-Hwan, et al.
Publicado: (2020) -
Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets
por: Kim, Sung-Hyun, et al.
Publicado: (2021)